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Thoracic electrical 
bioimpedance theory and 
clinical possibilities in 
perioperative medicine
ABSTRACT
This article is a short review of thoracic electrical bioimpedance (TEB) theory and clinical capabilities. Cardiac output 
measurement is used primarily to guide therapy in complex, critically ill patients. Thoracic electrical bioimpedance is one of 
several noninvasive techniques that have been investigated to measure cardiac output and other hemodynamic parameters. 
Opinions in current literature continue to be conflicting as to the utility of thoracic electrical bioimpedance to that purpose. 
There is a limited number of good designed studies but they imply TEB is an accurate and reliable noninvasive method for 
determining cardiac output/cardiac index and it would be valuable for patients and circumstances in which intracardiac 
pressures and mixed venous blood samples are not necessary.
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There are many high-risk patients who 
need the measurement of cardiac out-
put (CO) in the operation theatre and 
postoperative settings. (1,2) It is still at 
present a dilemma about invasive and 
noninvasive way of monitoring hemody-
namic function.
Invasive cardiac monitoring mea-sure-
ment is used primarily to guide ther-
apy in complex, critically ill patients, 
and during the per operative period in 
patients with high morbidity and mor-
tality risk. Invasive pulmonary artery 
catheterization has been the method 
of choice for the accurate evaluation of 
hemodynamic status.
The pulmonary artery catheter (PAC) 
is routinely used to measure cardiac 
output by thermo dilution (TD) method 
for patients undergoing coronary artery 
bypass surgery, but there are a large 
number of patients who undergo minor 
or minimally invasive surgery, who pre-
sented with severe cardiac disease. 
Patients in the intensive care unit who 
suffer from sepsis and great hemody-
namic disturbance also need compre-
hensive cardiac monitoring. (3)
However, we can truly ask ourselves: 
do we really need Swan-Ganz during 
a laparoscopic cholecystectomy if a 
cardiac condition is quite bad? There 
are many similar situations in everyday 
practice. 
It is widely recognized that the pulmo-
nary artery catheter (PAC) places the 
patient at risk for infection and many 
other complications. (4) That possibil-
ity and lack of Swan-Ganz experience 
in a majority of anaesthetists, force a 
constant effort to find good, reliable and 
accurate noninvasive hemodynamic 
monitoring.
When we speak about hemodynamic 
monitoring, at first we think about car-
diac output. There is no totally accurate 
method of measuring cardiac output, 
but it can be estimated on the basis 
of various assumptions. (5) CO per 
se means not much if we do not put 
it in relation with adequacy of oxygen 
transport, which is the ultimate goal 
of hemodynamic monitoring. Oxygen 
transport is a function of CO and arterial 
oxygen content. 
Cardiac output (CO) is assessed by 
measuring the volume of blood pumped 
by the heart in one minute. The amount 
of blood pumped by the left ventricle in 
one contraction is the stroke volume. 
The stroke volume (SV) multiplied by the 
heart rate (Hr) is the cardiac output: 
CO = SV Hr 
CO is directly proportional to the mean 
pressure drop over the whole of the 
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systemic arterial-venous circuit (i.e., 
mean arterial pressure (MAP) – central 
venous pressure (CVP)) and is inverse-
ly proportional to the total peripheral 
resistance (TPR) of the circuit.
CO ≈ (MAP – CVP) / TPR 
There is an analogous relationship in 
electricity. Ohm’s Law states that flow 
of current (I, analogous to CO) is equal 
to the voltage drop (V, analogous to 
the pressure drop) between two ends 
of a circuit, divided by the resistance to 
current flow (R, analogous to TPR). For 
direct current we can state:
I = V / R    
R = V / I    
If I = constant, a change in resistance 
(∆R) is proportional to a change in volt-
age (∆V):
∆R ≈ ∆V
For alternating current flow, resistance 
is known as impedance (Z) and is com-
plex, frequency-dependent parameter. 
For alternating current we can say that:
Z = V/ I
Z is measured in ohms. If I remains 
constant, then periodic changes in vol-
tage (∆V) produce concurrent changes 
in impedance (∆Z):
∆Z ≈ ∆V
This simple equation is fundamental 
to understanding SV determination by 
thoracic electrical bioimpedance (TEB). 
Thoracic Electrical Bioimpedance (TEB), 
with a symbol Z, is an electrical resist-
ance of the thorax to a high-frequency, 
very-low magnitude TEB measurement 
current. TEB utilizes a patient’s thorax as 
an impedance transducer.
The impedance to alternating current 
flow of a simple cylindrical electrical 
conductor is equal to its specific resist-
ance (ρ) times it length (L), divided by 
its cross-sectional area (A):
Z = ρL/A)
For simplicity, the thorax can be mod-
eled as a cylindrical conductor of length 
L, which has embedded, in parallel with 
the thoracic length, a smaller cylindri-
cal conductor, representing the great 
vessels (figure 1). In that small cylinder 
representing the vessels is blood of 
specific resistance ρb, with cross-sec-
ges in thoracic impedance (∆Z). 
The increased thoracic conductivity 
is caused by the systolic pumping of 
blood into the great vessels from the 
ventricles, caused by ventricular sys-
tole, and it is registered as decreases 
in impedance to current flow.
Time-varying pulsatile changes in aortic 
and pulmonic blood volume (∆V) are 
directly proportional to the time-varying, 
cardiac-induced impedance change 
(∆Z):
∆V (t) ≈ ρb (L2/Z02) ∆Z ; where Z0 
is the nonpulsatile base impedance 
measured.
The Base Impedance (Z0) is indirectly 
proportional to total content of thoracic 
fluids. We cannot identify individual 
conductance contributions of the intra-
vascular, intra-alveolar and interstitial 
compartments and therefore, we can 
see the thoracic fluid conductivity, 
which is then directly proportional to 
the thoracic fluids content (TFC). The 
TEB variations and changes (∆Z) are 
produced by: 
• slow changes of fluid levels in all tho-
racic compartments, 
• tidal changes of venous and pul-
monary blood volume caused by res-
piration,
Figure 1. Simple model of human 
thorax. Small cylinder represents 
great vessels with cross-sectional 
area Av, length L and specific resis-
tance of blood ρb. Remaining thoracic 
volume has cross-sectional area AT, 
length L and specific resistance ρT 
(ρb << ρT).
tional area labeled Av. The remaining 
volume of the cylinder is assumed to be 
homogenous with specific resistance 
ρT (ρ thorax) and cross-sectional area 
labeled AT.
It is assumed that the small cylinder 
has a varying cylindrical cross-sectional 
area: Av + ∆ Av(t), caused by aortic 
and pulmonary artery pulsations with 
each heart beat. If we assumed that 
ρb << ρT we can conclude that the 
change in Z with each heart beat is 
caused mostly by changes in the cross-
sectional areas of the great vessels 
∆ Av(t). Synthesizing this theory with 
Ohm’s Law, it comes about that the 
periodic increases in cross-sectional 
area (L remaining constant) and vol-
ume of the great vessels (∆ Av) must 
cause corresponding decreases in tho-
racic impedance and vice versa.
Systemic aortic blood pressure and 
expansion of the great vessels are 
accompanied by simultaneous chan-
Figure 2. ECG and ICG Waveforms. 
Q =  Ventricular depolarization, B = 
Opening aortic and pulmonic valves, 
C =  Maximal slope ∆Z, X =  Closure 
aortic valve, Y =  closure of pulmonic 
valve, O =  Opening mitral valve / 
rapid filling of ventricles.
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• volumetric and velocity (alignment 
of planes of erythrocytes as a function 
of blood velocity) changes of aortic 
blood produced by the heart's pump-
ing activity.
The cardiac origin of ∆Z is obvious when 
viewed in light of its electrocardiogram 
(ECG) counterpart (figure 2). Like ECG, 
TEB has important waveform charac-
teristics that reflect significant points in 
the cardiac cycle (figure 3). The change 
in impedance (∆Z) is measured from 
the baseline impedance Z0 (shown as 
dotted line).  Baseline impedance is 
inversely proportional to the amount of 
conductive material in the thorax. The 
thoracic fluid content parameter (TFC) 
is the inverse of baseline impedance, 
so TFC is directly proportional to the 
amount of conductive material in the 
thorax. As fluid in the chest increases, 
TFC increases. The first derivative (dz/
dt) of the delta Z waveform is used to 
identify the maximum upslope, shown 
as point C. This is used to calculate 
Velocity Index (VI), which is indicative 
of aortic blood velocity.  As the heart 
pumping ability is impaired, VI decreas-
es. The left ventricular ejection time 
(LVET) is the time from the opening of 
the aortic valve (B point)  to the closing 
(X point).  As the heart loses its ability 
to contract (systolic function worsens), 
LVET shortens.
The patient is connected to the monitor 
via a patient cable attached to eight 
solid-gel, disposable electrodes (figure 
4). The TEB measurement current is 
passed through the thorax in a direc-
tion parallel with the spine between the 
beginning of the thorax (the line at the 
root of the neck) and the end of the 
thorax (at the level of diaphragm - the 
xiphoid process level). Four dual sen-
sors with eight lead wires are placed on 
neck and chest. Current transmitted by 
outer electrodes seek the path of least 
resistance: blood filled aorta. Baseline 
impedance (resistance) is measured 
using inner electrodes. With each heart-
beat, blood volume and velocity in the 
aorta changes. Corresponding change 
in impedance is measured. Baseline 
and changes in impedance are used to 
measure and calculate hemodynamic 
parameters.
These four electrodes also detect four 
different vectors of the ECG signal. The 
Heart Rate (HR) is derived from the 
R-R intervals of the ECG signal. Due 
to the anatomical shape of the thorax, 
a preferential placement for all eight 
electrodes is along the frontal plane 
– the widest thoracic dimension. 
With TEB we can get many noninvasive 
parameters (table1).
From a clinical point of view, we can 
divide all this parameters into four 
groups (table 2).
We can use TEB for hemodynamic eval-
uation in many circumstances: 
• Fluid management for heart failure,
• Differentiation of cardiogenic from 
pulmonary causes of acute dyspnea,
• Optimization of atrioventricular inter-
val in cardiac pacemakers,
• Monitoring of patients for early diag-
nosis of rejection after heart transplan-
tation,
• Management of drug-resistant hyper-
tension,
• Evaluation of hemodynamic response 
in dehydrated patients,
• Management of patients with severe 
cardiac illness during surgery,
• Management of patients during inten-
sive care,
• Management of patients in the Emer-
gency Department,
• Noninvasive monitoring for early rec-
ognition and treatment of shock in high-
risk trauma and surgical patients.
In the per operative fluid management, 
which is everyday practice, thoracic 
fluid content (TFC) could be very appli-
cable parameter.
• A single TFC measurement indicates 
total conductivity of the chest that is 
affected by both intravascular and extra 
vascular fluid.
• Changes in TFC from a previous 
measurement represent changes in 
total fluid of the chest, intravascular 
and/or extra vascular volume.  
Although TFC does not correlate with 
PCWP, it is a very good indicator of 
thoracic fluid. Changes in TFC are very 
reliable indicators of changes in intra- 
or extra-vascular fluid volume.
There are many decompensated heart 
failure patients preoperative and in the 
intensive care unit. It is impossible to 
imagine that all of them are candidates 
for invasive monitoring. There is a place 
for TEB in the differentiation of cardio-
genic from pulmonary causes of acute 
dyspnea when history, physical exami-
nation, and standard assessment tools 
provide insufficient information. Some 
authors investigate usefulness of the 
impedance value on a scale of 1 to 
10 for each heart failure patient. (6) 
The mean usefulness rating was 7.9 
(95% Confidence Interval: 6.5 – 9.3). 
The researchers concluded that the 
baseline impedance value obtained 
from noninvasive hemodynamic moni-
toring with TEB accurately predicted 
the presence and severity of pulmonary 
Figure 3. The timing relationship 
between ECG and thoracic electrical 
bioimpedance: myocardial contraction 
starts at the Q-time of the ECG QRS 
complex. The Pre-Ejection Period 
(PEP) (isovolumic contraction) is 
defined as the elapsed time between 
the Q-time of the QRS complex and the 
opening of aortic valve. The ejection 
phase, outlined by the Ventricular 
Ejection Time (VET), starts by opening 
of aortic valve and ends by its closure 
(S2-time). During the initial portion 
of ejection phase the aorta distends 
and the thorax, therefore, becomes 
more conductive; at the same time 
the velocity of blood increases, more 
erythrocytes are aligned so their 
planes are parallel with the main axis 
of aorta and, therefore, the blood 
becomes more conductive. 
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edema and can serve as an important 
adjunct in the treatment of heart failure 
patients.
In many operative procedures TEB may 
be used instead of invasive techniques 
as it is accurate, reliable and simple 
to use, with proven efficacy. (7) It has 
the additional advantage of allowing 
continuous monitoring of cardiac index 
by noninvasive means, and gives the 
anesthetist information regarding stroke 
volume, cardiac and ejection veloc-
ity indices in a “real-time” manner, in 
response to drugs or surgical stimuli.
It is well known that respiration and 
artificial ventilation result in cyclic fluc-
tuations of the cardiac output determi-
nation by thermodilution (TD). Because 
of the modulation shift during changing 
ventilation patterns, i.e. different levels 
of PEEP, researchers doubt that the TD 
technique is an appropriate method for 
studying modulations of cardiac output 
dependent on artificial ventilation.
Castor and colleges in their study find 
that TEB is an accurate and reproduc-
ible method for determination of cardiac 
output under these changing respiratory 
patterns during artificial ventilation. (8)
There are many studies that compare 
TEB and direct Fick cardiac output 
methods. In a prospective study, Van 
DeWater et al. (9) compared the accu-
racy of TEB to thermodilution (CO-TD) 
in postoperative coronary artery bypass 
graft (CABG) patients. This study took 
place in a cardiovascular-thoracic 
surgery intensive care unit (ICU). The 
study included 53 post-CABG patients 
from whom 210 pairs of cardiac output 
measurements were made. The TEB 
cardiac output was determined simul-
taneously with the TD cardiac output. 
The authors reported that when com-
paring TEB to TD, they found that the 
bias, precision, correlation slope, and 
intercept were equivalent to TD. The 
authors stated that in those circum-
stances in which intracardiac pressures 
and mixed venous blood samples are 
not necessary, TEB is preferable to 
invasive TD method in determining car-
diac output. The authors stated that the 
TEB monitor allows for quick and easy 
cardiac output monitoring and systemic 
vascular resistance in clinical areas 
where the pulmonary artery catheter is 
not typically utilized (e.g., emergency 
department, sub acute care, hyper-
tension and heart failure). “The latest 
TEB technology for determining CO is 
less variable and more reproducible 
in an intrapatient sense than is CO-
TD.” TEB is reproducible, especially 
in comparison to serial measurements 
using Thermo dilution. The historical 
standard for hemodynamic measure-
ment, thermo dilution (TD), shows only 
modest correlation when compared 
to itself. The SD for thermodilution is 
about 1 liter/minute or about 20% of the 
average CO. TEB shows very high cor-
relation when compared to itself, and 
lower standard deviation for multiple 
TEB measurements.
In the other study of 23 adults in the 
intraoperative and post operative set-
tings, the correlation coefficient between 
the two methods was r=0.89, p<0.001. 
(10) In a study of 68 critically ill patients, 
changes in cardiac output estimated 
by TEB were found to closely correlate 
with values obtained with TD method r 
= 0.86, p<0.001. (11)
Shock and shock-related organ failure 
account for most deaths in trauma and 
surgical patients. The study of Asensio 
Figure 4. Location of the 8 electrodes along the TEB transducer - a patient’s thorax. The top and bottom pair is a 
source and sink of the TEB measurement current, the inner pairs, located at the root of the neck (the beginning of the 
transducer) and the diaphragm level, i.e., the xiphoid process level (the end of the transducer), are used for sensing 
both the TEB signal and 4 different vectors of the ECG signal. a) Front view b) Lateral view
a) b)
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Table 1. Parameters captured by TEB measurement.and colleges examines the use of non-
invasive methods, including thoracic 
electrical bioimpedance (TEB) for early 
recognition and treatment of shock in 
high-risk trauma and surgical patients. 
(12) This study involved a series of trau-
ma patients entering the emergency 
department. It reviews the use of inva-
sive and noninvasive monitoring meth-
ods in these patients to describe the 
temporal patterns of cardiac, pulmo-
nary, and tissue perfusion functions in 
the early phase of trauma. The authors 
concluded that noninvasive monitoring 
is easy to apply, safe, inexpensive, and 
more cost-effective than invasive moni-
toring. High-risk patients might profit by 
earlier noninvasive hemodynamic mon-
itoring. If noninvasive monitoring identi-
fies circulatory problems earlier, then 
even more expeditious therapy could 
be given to achieve optimal physiologic 
goals that improve outcome.
Shoemaker and colleges in their study 
evaluate the feasibility of multicompo-
nent hemodynamic monitoring in criti-
cal emergency patients and compares 
the technique of TEB with simultaneous 
monitoring by the pulmonary artery ther-
modilution catheter. (13) The research-
ers concluded that: “Noninvasive moni-
toring can provide hemodynamic and 
perfusion information previously avail-
able by invasive thermodilution cath-
eters. Such noninvasive monitoring can 
display continuous on-line real-time 
data, allowing immediate recognition of 
circulatory abnormalities and providing 
a means to titrate therapy to appropri-
ate therapeutic goals.”
Potential limitations in use of TEB are 
states with HR > 250 bpm, septic 
shock (end stage sepsis), severe aor-
tic valve regurgitation, extremely high 
blood pressure (MAP > 130) and intra-
aortic balloon pump. Also, extremely tall 
(>210 cm) and low (<120 cm) patients 
and patients under 35 kg and over 170 
kg lose out the accuracy of measure-
ment by TEB.
Conclusion
Thoracic electrical bioimpedance is one 
of several noninvasive techniques that 
have been used to measure cardiac 
output and other hemodynamic param-
eters. It is a simple, cost-effective tool 
for clinical assessment. TEB repeatedly 
demonstrated good correlation with 
other clinical measures of cardiac func-
tion and associated parameters. The 
advancements in hardware, enhanced 
algorithms used in software, and clini-
cal experience may well expand the 
clinical applications for this continuous 
noninvasive hemodynamic monitoring.
We must say that evidence in the cur-
rent literature continue to be conflicting 
as to the utility of TEB in measuring 
hemodynamic parameters but TEB 
has demonstrated clinically acceptable 
accuracy with lower cost per patient in 
those circumstances in which intrac-
ardiac pressures and mixed venous 
blood samples are not necessary. Fur-
thermore, it enables us to quickly and 
easily monitor CO and SVR in clinical 
areas where the invasive monitoring 
is not typically utilized. The use of TEB 
may potentially improve patient out-
comes.
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Table 2. The hemodynamic parameters measured and calculated by TEB reflect cardiac flow (output) and the four 
determinants of cardiac output (HR, preload, afterload, and contractility).
Flow Stroke Volume / Index (SV / SI)
Cardiac Output / Index (CO / CI)
Resistance
Systemic Vascular Resistance (SVR)
Index (SVRI)
Contractility  
Systolic Time Ratio (STR)
Pre-ejection Period (PEP)
LV Ejection Time (LVET)
Velocity Index (VI)
Acceleration Index (ACI)
Fluid   Thoracic Fluid Content (TFC)
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